Form 4: MicroVision General Counsel Reports Significant RSU Vesting and New Grant, Alongside Tax-Related Stock Sale

MicroVision's General Counsel, Drew G. Markham, reported the vesting of over 259,000 restricted stock units (RSUs) into common stock, a subsequent tax-related sale of shares, and a new grant of 360,000 RSUs.

Summary

• Drew G. Markham, General Counsel of MicroVision, Inc. (MVIS), reported multiple transactions involving company stock and restricted stock units (RSUs).
• On June 4, 2025, 139,688 vested RSUs were distributed to Mr. Markham as common stock, without payment, based on the achievement of performance objectives under the 2025 Executive Bonus Plan.
• Also on June 4, 2025, an additional 119,880 RSUs, part of a grant from June 4, 2024, vested and converted into common stock.
• Following these vestings, Mr. Markham's direct beneficial ownership of common stock increased to 448,074 shares.
• On June 5, 2025, 69,140 shares of common stock were disposed of at an execution price of $1.123 per share in a non-discretionary 'sell-to-cover' transaction for tax withholding purposes.
• After the sell-to-cover transaction, Mr. Markham's direct beneficial ownership of common stock was 378,934 shares.
• On June 6, 2025, the Compensation Committee approved a new grant of 360,000 RSUs to Mr. Markham, which are scheduled to vest 33% annually until fully vested on June 6, 2028, subject to continued employment.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While there's a sale of shares, it's a routine tax-related transaction. The significant vesting of RSUs and a new large RSU grant indicate continued executive compensation and retention, which can be viewed positively by investors as it aligns management's interests with the company's performance.

Positives

• The vesting of a significant number of RSUs (259,568 shares in total) indicates the achievement of performance objectives and continued executive compensation.
• A new grant of 360,000 RSUs demonstrates ongoing commitment to executive retention and aligns management's interests with long-term shareholder value through future vesting schedules.

Negatives

• A portion of the newly vested shares (69,140 shares) was sold to cover tax obligations, which reduces the immediate increase in the insider's direct ownership.

Future Outlook

The reporting person has future RSU grants scheduled to vest annually, with the 360,000 RSU grant from June 6, 2025, scheduled to fully vest by June 6, 2028, contingent on continued employment.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, specifically related to executive compensation through restricted stock units and subsequent tax-related sales. Such transactions are common across all industries for publicly traded companies.

Corporate Governance

Stakeholder Impact

• Shareholders: The vesting and new grant of RSUs indicate continued alignment of executive incentives with company performance, potentially viewed positively for long-term value creation. The sell-to-cover is a routine tax event and not indicative of a discretionary sale.
• Employees: The RSU grants and vesting are part of the company's executive compensation framework, which can influence overall compensation strategies and morale.

Next Steps

• Future annual vesting of the 360,000 RSU grant, with the next vesting scheduled for June 6, 2026.
• Continued employment of Drew G. Markham with MicroVision, Inc. for future RSU vesting.

Key Dates

Keywords

MicroVision, MVIS, SEC Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Executive Compensation, Stock Sale, Drew G. Markham, Corporate Governance